Cytokine Storm Clinical Trial
Official title:
The Effect of Omega-3 Supplements on the Serum Levels of Selected Cytokines Involved in Cytokine Storm of Covid-19; A Randomized Clinical Trial in the Covid-19 Uninfected Jordanian People
Verified date | February 2022 |
Source | Applied Science Private University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The trial was designed to assess the effect of daily dose of 300 mg omega-3 supplements for 2 months on the selected interleukins levels in uninfected people with Covid-19.
Status | Completed |
Enrollment | 100 |
Est. completion date | February 28, 2021 |
Est. primary completion date | December 15, 2020 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 30 Years to 66 Years |
Eligibility | Inclusion Criteria: - Inclusion criteria included males and females in the age range of 30-66 years without a medical diagnosis of COVID-19 infection. Exclusion Criteria: - Exclusion criteria included males or females diagnosed with any chronic immune problems, including autoimmune diseases, chronic or severe infections. - Pregnant, breastfeeding, and females using hormonal contraceptives were also excluded. |
Country | Name | City | State |
---|---|---|---|
Jordan | Mahmoud S Abu-Samak | Amman |
Lead Sponsor | Collaborator |
---|---|
Applied Science Private University |
Jordan,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | IL-1 beta | pg/mL | (2 months ; 60 days ) | |
Primary | IL-6 | pg/ml | (2 months ; 60 days ) | |
Primary | TNF alpha | pg/ml | (2 months ; 60 days ) | |
Secondary | Lipid profile | mg/dL | (2 months ; 60 days ) | |
Secondary | Fasting blood glucose | mg/dl | (2 months ; 60 days ) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03685383 -
Cytokine Adsorption in Post-cardiac Arrest Syndrome in Patients Requiring Extracorporeal Cardiopulmonary Resuscitation
|
N/A | |
Recruiting |
NCT05491304 -
Cytokine Guided Risk Stratification and Treatment in Pediatric Hemophagocytic Lymphohistiocytosis
|
Phase 4 | |
Suspended |
NCT04385771 -
Cytokine Adsorption in Patients With Severe COVID-19 Pneumonia Requiring Extracorporeal Membrane Oxygenation
|
N/A | |
Completed |
NCT05307601 -
Immune Response Following COVID-19 in Hemodialysis Patients
|
||
Completed |
NCT04476745 -
The Effect of D3 on Selected Cytokines Involved in Cytokine Storm in the Covid-19 Uninfected Jordanian People
|
N/A | |
Completed |
NCT04798677 -
Efficacy and Tolerability of ABBC1 in Volunteers Receiving the Influenza or Covid-19 Vaccine
|
N/A | |
Completed |
NCT01302223 -
Keratinocyte Growth Factor and Cytokines in Burns.
|
N/A | |
Not yet recruiting |
NCT05013034 -
Exploratory Regimen of Basiliximab for Treatment of Pulmonary Cytokine Storm in SARS-CoV-2 Hospitalized Adult Patients
|
Phase 2 | |
Completed |
NCT04910893 -
Cytokine Adsorption in Severe, Refractory Septic Shock
|
N/A | |
Completed |
NCT04854252 -
Inflammatory Response to Opioid Versus Opioid Free Anesthesia
|
N/A | |
Completed |
NCT04366908 -
Prevention and Treatment With Calcifediol of COVID-19 Induced Acute Respiratory Syndrome
|
Phase 2 | |
Terminated |
NCT04415073 -
A Phase 2 Study to Evaluate Axatilimab for Hospitalized Participants With Respiratory Involvement Secondary to COVID-19
|
Phase 2 | |
Completed |
NCT04377308 -
Fluoxetine to Reduce Intubation and Death After COVID19 Infection
|
Phase 4 | |
Completed |
NCT04324528 -
Cytokine Adsorption in Severe COVID-19 Pneumonia Requiring Extracorporeal Membrane Oxygenation
|
N/A | |
Completed |
NCT05476848 -
Relationship Between Oral Findings and Salivary Factors in Sars-Cov-2 Patients
|
N/A | |
Completed |
NCT04913298 -
Prospective Study for the Application of Cytosorb® in Critically Ill Patients
|
N/A | |
Recruiting |
NCT04753476 -
Treatment of Severe COVID-19 Patients Using Secretome of Hypoxia-Mesenchymal Stem Cells in Indonesia
|
Phase 2 | |
Terminated |
NCT04327505 -
Safety and Efficacy of Hyperbaric Oxygen for ARDS in Patients With COVID-19
|
Phase 2/Phase 3 | |
Withdrawn |
NCT04433078 -
RepurpoSing Old Drugs TO SuppRess a Modern Threat: COVID-19 STORM
|
Phase 2 | |
Completed |
NCT04901338 -
Cytokine Hemoadsorption in ECMO Patients
|